Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Multiple Sclerosis Performance Test: Technical Development and Usability.

Rhodes JK, Schindler D, Rao SM, Venegas F, Bruzik ET, Gabel W, Williams JR, Phillips GA, Mullen CC, Freiburger JL, Mourany L, Reece C, Miller DM, Bethoux F, Bermel RA, Krupp LB, Mowry EM, Alberts J, Rudick RA.

Adv Ther. 2019 May 3. doi: 10.1007/s12325-019-00958-x. [Epub ahead of print]

PMID:
31054035
2.

Brief Computer-Based Information Processing Measures are Linked to White Matter Integrity in Pediatric-Onset Multiple Sclerosis.

Bartlett E, Shaw M, Schwarz C, Feinberg C, DeLorenzo C, Krupp LB, Charvet LE.

J Neuroimaging. 2019 Jan;29(1):140-150. doi: 10.1111/jon.12566. Epub 2018 Oct 4.

PMID:
30285300
3.

Timed instrumental activities of daily living in multiple sclerosis: The test of everyday cognitive ability (TECA).

Charvet LE, Shaw MT, Sherman K, Haas S, Krupp LB.

Mult Scler Relat Disord. 2018 Jul;23:69-73. doi: 10.1016/j.msard.2018.05.001. Epub 2018 May 3.

PMID:
29778936
4.

Correction: Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial.

Charvet LE, Yang J, Shaw MT, Sherman K, Haider L, Xu J, Krupp LB.

PLoS One. 2018 Jan 30;13(1):e0192317. doi: 10.1371/journal.pone.0192317. eCollection 2018.

5.

Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward.

Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, Rao SM.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):832-842. doi: 10.1017/S1355617717000959. Review.

PMID:
29198279
6.

Remotely supervised transcranial direct current stimulation for the treatment of fatigue in multiple sclerosis: Results from a randomized, sham-controlled trial.

Charvet LE, Dobbs B, Shaw MT, Bikson M, Datta A, Krupp LB.

Mult Scler. 2018 Nov;24(13):1760-1769. doi: 10.1177/1352458517732842. Epub 2017 Sep 22.

7.

Adverse Childhood Experiences Are Linked to Age of Onset and Reading Recognition in Multiple Sclerosis.

Shaw MT, Pawlak NO, Frontario A, Sherman K, Krupp LB, Charvet LE.

Front Neurol. 2017 Jun 2;8:242. doi: 10.3389/fneur.2017.00242. eCollection 2017.

8.

Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial.

Charvet LE, Yang J, Shaw MT, Sherman K, Haider L, Xu J, Krupp LB.

PLoS One. 2017 May 11;12(5):e0177177. doi: 10.1371/journal.pone.0177177. eCollection 2017. Erratum in: PLoS One. 2018 Jan 30;13(1):e0192317.

9.

Cognitive impairment in pediatric-onset multiple sclerosis is detected by the Brief International Cognitive Assessment for Multiple Sclerosis and computerized cognitive testing.

Charvet LE, Shaw M, Frontario A, Langdon D, Krupp LB.

Mult Scler. 2018 Apr;24(4):512-519. doi: 10.1177/1352458517701588. Epub 2017 Mar 21.

PMID:
28322606
10.

Pediatric multiple sclerosis: Cognition and mood.

Amato MP, Krupp LB, Charvet LE, Penner I, Till C.

Neurology. 2016 Aug 30;87(9 Suppl 2):S82-7. doi: 10.1212/WNL.0000000000002883. Review.

PMID:
27572867
11.

Consensus definitions for pediatric MS and other demyelinating disorders in childhood.

Tardieu M, Banwell B, Wolinsky JS, Pohl D, Krupp LB.

Neurology. 2016 Aug 30;87(9 Suppl 2):S8-S11. doi: 10.1212/WNL.0000000000002877. Review.

PMID:
27572866
12.

Pediatric multiple sclerosis: Perspectives from adolescents and their families.

Krupp LB, Rintell D, Charvet LE, Milazzo M, Wassmer E.

Neurology. 2016 Aug 30;87(9 Suppl 2):S4-7. doi: 10.1212/WNL.0000000000002879.

PMID:
27572860
13.

International Pediatric MS Study Group Global Members Symposium report.

Wassmer E, Chitnis T, Pohl D, Amato MP, Banwell B, Ghezzi A, Hintzen RQ, Krupp LB, Makhani N, Rostásy K, Tardieu M, Tenembaum S, Waldman A, Waubant E, Kornberg AJ.

Neurology. 2016 Aug 30;87(9 Suppl 2):S110-6. doi: 10.1212/WNL.0000000000002880. Review.

PMID:
27572855
14.

Characteristics of Children and Adolescents With Multiple Sclerosis.

Belman AL, Krupp LB, Olsen CS, Rose JW, Aaen G, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze T, Ness J, Rodriguez M, Tillema JM, Waubant E, Weinstock-Guttman B, Casper TC; US Network of Pediatric MS Centers.

Pediatrics. 2016 Jul;138(1). pii: e20160120. doi: 10.1542/peds.2016-0120.

15.

Fatigue in Parkinson's disease: report from a mutidisciplinary symposium.

Friedman JH, Beck JC, Chou KL, Clark G, Fagundes CP, Goetz CG, Herlofson K, Kluger B, Krupp LB, Lang AE, Lou JS, Marsh L, Newbould A, Weintraub D.

NPJ Parkinsons Dis. 2016;2. pii: 15025. Epub 2016 Jan 14.

16.

A case-control study of dietary salt intake in pediatric-onset multiple sclerosis.

McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Lulu S, Ness J, Harris Y, Rubin J, Candee M, Krupp LB, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos LF, Laraia B, Rose J, Roalstad S, Simmons T, Casper TC, Waubant E.

Mult Scler Relat Disord. 2016 Mar;6:87-92. doi: 10.1016/j.msard.2016.02.011. Epub 2016 Feb 12.

17.

Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.

Krupp LB, Pohl D, Ghezzi A, Boyko A, Tenembaum S, Chen L, Aycardi E, Banwell B; REPLAY Study Group.

J Neurol Sci. 2016 Apr 15;363:33-8. doi: 10.1016/j.jns.2016.01.023. Epub 2016 Jan 15.

18.

Behavioral Symptoms in Pediatric Multiple Sclerosis: Relation to Fatigue and Cognitive Impairment.

Charvet L, Cersosimo B, Schwarz C, Belman A, Krupp LB.

J Child Neurol. 2016 Jul;31(8):1062-7. doi: 10.1177/0883073816636227. Epub 2016 Mar 9.

19.

Genetic predictors of relapse rate in pediatric MS.

Graves JS, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant E; U.S. Network of Pediatric MS Centers.

Mult Scler. 2016 Oct;22(12):1528-1535. Epub 2016 Jan 14.

20.

Remotely-delivered cognitive remediation in multiple sclerosis (MS): protocol and results from a pilot study.

Charvet LE, Shaw MT, Haider L, Melville P, Krupp LB.

Mult Scler J Exp Transl Clin. 2015 Oct 5;1:2055217315609629. doi: 10.1177/2055217315609629. eCollection 2015 Jan-Dec.

21.

Neuropsychological correlates of multiple sclerosis across the lifespan.

Nunan-Saah J, Paulraj SR, Waubant E, Krupp LB, Gomez RG.

Mult Scler. 2015 Oct;21(11):1355-64. doi: 10.1177/1352458515586088. Epub 2015 Jul 10. Review.

PMID:
26163074
22.

The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).

Charvet LE, Beekman R, Amadiume N, Belman AL, Krupp LB.

J Neurol Sci. 2014 Jun 15;341(1-2):79-84. doi: 10.1016/j.jns.2014.04.006. Epub 2014 Apr 13.

PMID:
24792098
23.

Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.

Charvet LE, O'Donnell EH, Belman AL, Chitnis T, Ness JM, Parrish J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Krupp LB; US Network of Pediatric MS Centers.

Mult Scler. 2014 Oct;20(11):1502-10. doi: 10.1177/1352458514527862. Epub 2014 Mar 31.

24.

Social cognition in pediatric-onset multiple sclerosis (MS).

Charvet LE, Cleary RE, Vazquez K, Belman AL, Krupp LB; US Network for Pediatric MS.

Mult Scler. 2014 Oct;20(11):1478-84. doi: 10.1177/1352458514526942. Epub 2014 Mar 19.

25.

Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosis.

Vingara LK, Yu HJ, Wagshul ME, Serafin D, Christodoulou C, Pelczer I, Krupp LB, Maletić-Savatić M.

Neuroimage. 2013 Nov 15;82:586-94. doi: 10.1016/j.neuroimage.2013.05.125. Epub 2013 Jun 7.

26.

Subcutaneous interferon Beta-1a in pediatric multiple sclerosis: a retrospective study.

Tenembaum SN, Banwell B, Pohl D, Krupp LB, Boyko A, Meinel M, Lehr L, Rocak S, Cantogno EV, Moraga MS, Ghezzi A; REPLAY Study Group.

J Child Neurol. 2013 Jul;28(7):849-56. doi: 10.1177/0883073813488828. Epub 2013 May 10.

PMID:
23666046
27.

Parainfectious meningo-encephalo-radiculo-myelitis (cat scratch disease, Lyme borreliosis, brucellosis, botulism, legionellosis, pertussis, mycoplasma).

Greenblatt D, Krupp LB, Belman AL.

Handb Clin Neurol. 2013;112:1195-207. doi: 10.1016/B978-0-444-52910-7.00041-6. Review.

PMID:
23622329
28.

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, Ghezzi A, Hintzen R, Kornberg A, Pohl D, Rostasy K, Tenembaum S, Wassmer E; International Pediatric Multiple Sclerosis Study Group.

Mult Scler. 2013 Sep;19(10):1261-7. doi: 10.1177/1352458513484547. Epub 2013 Apr 9.

PMID:
23572237
29.

International Pediatric MS Study Group Clinical Trials Summit: meeting report.

Chitnis T, Tardieu M, Amato MP, Banwell B, Bar-Or A, Ghezzi A, Kornberg A, Krupp LB, Pohl D, Rostasy K, Tenembaum S, Waubant E, Wassmer E.

Neurology. 2013 Mar 19;80(12):1161-8. doi: 10.1212/WNL.0b013e318288694e.

30.

Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy.

Kluger BM, Krupp LB, Enoka RM.

Neurology. 2013 Jan 22;80(4):409-16. doi: 10.1212/WNL.0b013e31827f07be. Review.

31.

Copy number variation in pediatric multiple sclerosis.

McElroy JP, Krupp LB, Johnson BA, McCauley JL, Qi Z, Caillier SJ, Gourraud PA, Yu J, Nathanson L, Belman AL, Hauser SL, Waubant E, Hedges DJ, Oksenberg JR.

Mult Scler. 2013 Jul;19(8):1014-21. doi: 10.1177/1352458512469696. Epub 2012 Dec 13.

32.

Treatment of cognitive impairment in multiple sclerosis: position paper.

Amato MP, Langdon D, Montalban X, Benedict RH, DeLuca J, Krupp LB, Thompson AJ, Comi G.

J Neurol. 2013 Jun;260(6):1452-68. doi: 10.1007/s00415-012-6678-0. Epub 2012 Nov 23. Review.

PMID:
23180174
33.

Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.

Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Yeh A, Krupp LB; Network of Pediatric MS Centers of Excellence.

J Child Neurol. 2013 Jan;28(1):102-7. doi: 10.1177/0883073812464816. Epub 2012 Nov 15.

34.

Pediatric multiple sclerosis: what we know and where are we headed?

MacAllister WS, Christodoulou C, Milazzo M, Preston TE, Serafin D, Krupp LB, Harder L.

Child Neuropsychol. 2013;19(1):1-22. doi: 10.1080/09297049.2011.639758. Epub 2012 Mar 1. Review.

PMID:
22375830
35.

Unemployment in multiple sclerosis: the contribution of personality and disease.

Strober LB, Christodoulou C, Benedict RH, Westervelt HJ, Melville P, Scherl WF, Weinstock-Guttman B, Rizvi S, Goodman AD, Krupp LB.

Mult Scler. 2012 May;18(5):647-53. doi: 10.1177/1352458511426735. Epub 2011 Dec 19.

PMID:
22183935
36.

Multiple white matter tract abnormalities underlie cognitive impairment in RRMS.

Yu HJ, Christodoulou C, Bhise V, Greenblatt D, Patel Y, Serafin D, Maletic-Savatic M, Krupp LB, Wagshul ME.

Neuroimage. 2012 Feb 15;59(4):3713-22. doi: 10.1016/j.neuroimage.2011.10.053. Epub 2011 Oct 29.

PMID:
22062194
37.

Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.

Krupp LB, Christodoulou C, Melville P, Scherl WF, Pai LY, Muenz LR, He D, Benedict RH, Goodman A, Rizvi S, Schwid SR, Weinstock-Guttman B, Westervelt HJ, Wishart H.

Neurology. 2011 Apr 26;76(17):1500-7. doi: 10.1212/WNL.0b013e318218107a.

38.

Regression-based pediatric norms for the brief visuospatial memory test: revised and the symbol digit modalities test.

Smerbeck AM, Parrish J, Yeh EA, Hoogs M, Krupp LB, Weinstock-Guttman B, Benedict RH.

Clin Neuropsychol. 2011 Apr;25(3):402-12. doi: 10.1080/13854046.2011.554445. Epub 2011 Mar 7.

PMID:
21391150
39.

Visual-cognitive processing deficits in pediatric multiple sclerosis.

Smerbeck AM, Parrish J, Serafin D, Yeh EA, Weinstock-Guttman B, Hoogs M, Krupp LB, Benedict RH.

Mult Scler. 2011 Apr;17(4):449-56. doi: 10.1177/1352458510391689. Epub 2011 Feb 22.

PMID:
21343232
40.

Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.

Mowry EM, James JA, Krupp LB, Waubant E.

Mult Scler. 2011 Jun;17(6):666-71. doi: 10.1177/1352458510394398. Epub 2011 Jan 6. Erratum in: Mult Scler. 2011 Dec;17(12):1539.

41.

Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis.

Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR 2nd, Weinstock-Guttman B; National Network of Pediatric MS Centers of Excellence.

Arch Neurol. 2011 Apr;68(4):437-44. doi: 10.1001/archneurol.2010.325. Epub 2010 Dec 13.

PMID:
21149803
42.

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.

Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, Marinucci LN, Blight AR; MSF204 Investigators.

Ann Neurol. 2010 Oct;68(4):494-502. doi: 10.1002/ana.22240.

PMID:
20976768
43.

Down a slippery slope: cognitive changes in pediatric MS.

Krupp LB, Benedict RH.

Neurology. 2010 Sep 28;75(13):1128-9. doi: 10.1212/WNL.0b013e3181f7a2c3. No abstract available.

PMID:
20876464
44.

Multiple sclerosis-associated fatigue.

Krupp LB, Serafin DJ, Christodoulou C.

Expert Rev Neurother. 2010 Sep;10(9):1437-47. doi: 10.1586/ern.10.99. Review.

PMID:
20819014
45.

Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.

Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, McDonald JC, Oksenberg JR, Bacchetti P, Waubant E.

Ann Neurol. 2010 May;67(5):618-24. doi: 10.1002/ana.21972.

PMID:
20437559
46.

Younger children with MS have a distinct CSF inflammatory profile at disease onset.

Chabas D, Ness J, Belman A, Yeh EA, Kuntz N, Gorman MP, Strober JB, De Kouchkovsky I, McCulloch C, Chitnis T, Rodriguez M, Weinstock-Guttman B, Krupp LB, Waubant E; US Network of Pediatric MS Centers of Excellence.

Neurology. 2010 Feb 2;74(5):399-405. doi: 10.1212/WNL.0b013e3181ce5db0.

47.

Fatigue and quality of life in pediatric multiple sclerosis.

MacAllister WS, Christodoulou C, Troxell R, Milazzo M, Block P, Preston TE, Bender HA, Belman A, Krupp LB.

Mult Scler. 2009 Dec;15(12):1502-8. doi: 10.1177/1352458509345902. Epub 2009 Nov 13.

PMID:
19965517
48.

Psychiatric comorbidity in pediatric patients with demyelinating disorders.

Weisbrot DM, Ettinger AB, Gadow KD, Belman AL, MacAllister WS, Milazzo M, Reed ML, Serrano D, Krupp LB.

J Child Neurol. 2010 Feb;25(2):192-202. doi: 10.1177/0883073809338519. Epub 2009 Sep 22.

PMID:
19773460
49.

Protein expression profiles in pediatric multiple sclerosis: potential biomarkers.

Rithidech KN, Honikel L, Milazzo M, Madigan D, Troxell R, Krupp LB.

Mult Scler. 2009 Apr;15(4):455-64. doi: 10.1177/1352458508100047.

PMID:
19324981
50.

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.

Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR; Fampridine MS-F203 Investigators.

Lancet. 2009 Feb 28;373(9665):732-8. doi: 10.1016/S0140-6736(09)60442-6.

PMID:
19249634

Supplemental Content

Loading ...
Support Center